Skip to Main Content

Author Details

David Wu
University of Washington
2010
57
22
PMIDPaper TitleJournal TitlePublished Year
37206249Ibrutinib response in a patient with refractory mixed essential cryoglobulinemia.EJHaem2023
34724537Potential for Process Improvement of Clinical Flow Cytometry by Incorporating Real-Time Automated Screening of Data to Expedite Addition of Antibody Panels.Am J Clin Pathol2022
36130297Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.Blood2022
34463316Clinicopathologic Findings in Patients With Initial Diagnosis of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) in Colorectal Mucosa.Am J Clin Pathol2022
33990705Myeloid/lymphoid neoplasms with FLT3 rearrangement.Mod Pathol2021
31571375Flow cytometric features of incidental indolent T lymphoblastic proliferations.Cytometry B Clin Cytom2020
33284946International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.Blood Adv2020
32894785Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease.Am J Hematol2020
32165484How I curate: applying American Society of Hematology-Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel rules for <i>RUNX1</i> variant curation for germline predisposition to myeloid malignancies.Haematologica2020
30417521Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1.Cytometry B Clin Cytom2019
31816062Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion.Blood Adv2019
31648317ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants.Blood Adv2019
31533919New approaches to molecular monitoring in CML (and other diseases).Blood2019
30779029Flow Cytometry for Non-Hodgkin and Hodgkin Lymphomas.Methods Mol Biol2019
31141139Molecular and Cytogenetic Education in Hematopathology Fellowship.Am J Clin Pathol2019
28970176Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes.Biol Blood Marrow Transplant2018
35135104Somatic Reversion of Germline <i>BRCA2</i> Mutation Confers Resistance to Poly(ADP-ribose) Polymerase Inhibitor Therapy.JCO Precis Oncol2018
29549183Ultrasensitive Detection of Chimerism by Single-Molecule Molecular Inversion Probe Capture and High-Throughput Sequencing of Copy Number Deletion Polymorphisms.Clin Chem2018
29684564Deep NPM1 Sequencing Following Allogeneic Hematopoietic Cell Transplantation Improves Risk Assessment in Adults with NPM1-Mutated AML.Biol Blood Marrow Transplant2018
29157618Pathology of Castleman Disease.Hematol Oncol Clin North Am2018
29284596Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL.Blood2018
29269802Donor derived T-cell large granular lymphocyte leukemia after cord blood transplant for pediatric T-cell lymphoblastic leukemia.Bone Marrow Transplant2018
29194092Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma.Am J Surg Pathol2018
28735487Targeted Next-Generation Sequencing of Acute Leukemia.Methods Mol Biol2017
28087540International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.Blood2017
28978712Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.J Virol2017
29138337Correction for Gutierrez et al., "Ets-1 Is Required for the Activation of VEGFR3 during Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Endothelial Cells".J Virol2017
28572161Ultrasensitive detection of acute myeloid leukemia minimal residual disease using single molecule molecular inversion probes.Haematologica2017
26084540Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.Cytometry B Clin Cytom2016
26650888Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma.Genes Chromosomes Cancer2016
26348890Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission.Biol Blood Marrow Transplant2016
27751357Jumping translocations in myelodysplastic syndromes.Cancer Genet2016
27775693Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas.Bone Marrow Transplant2016
27273345Cross-Platform DNA Encoding for Single-Cell Imaging of Gene Expression.Angew Chem Int Ed Engl2016
27149025Clinical Experience With Modified, Single-Tube T-Cell Receptor Vβ Flow Cytometry Analysis for T-Cell Clonality.Am J Clin Pathol2016
27148939CADD score has limited clinical validity for the identification of pathogenic variants in noncoding regions in a hereditary cancer panel.Genet Med2016
27145535Early T-Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia.Pediatr Blood Cancer2016
26907630Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy.Blood2016
25091590Apparent CD19 expression by natural killer cells: a potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemia.Cytometry B Clin Cytom2015
26276783Computer-aided detection of rare tumor populations in flow cytometry: an example with classic Hodgkin lymphoma.Am J Clin Pathol2015
26398831Durable Response to Tyrosine Kinase Inhibitor Therapy in a Lung Cancer Patient Harboring Epidermal Growth Factor Receptor Tandem Kinase Domain Duplication.J Thorac Oncol2015
25044944Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue.Cytometry B Clin Cytom2015
24189654Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens.J Mol Diagn2014
24976005Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue.Cytometry B Clin Cytom2014
24970842Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH.Clin Cancer Res2014
25046149Apparent CD19 expression by natural killer cells: A potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemia.Cytometry B Clin Cytom2014
24743218Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing.Mod Pathol2014
23296956Flow cytometry for non-Hodgkin and classical Hodgkin lymphoma.Methods Mol Biol2013
24038887Utility of flow cytometry for immunophenotyping double-hit lymphomas.Cytometry B Clin Cytom2013
24157944Using synthetic templates to design an unbiased multiplex PCR assay.Nat Commun2013
  • 1 - 50 of 57

Recommended Authors

Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Huntsman Cancer Institute at the University of Utah.
Career Start Year 2012
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 3
Institute of Pathology, Heidelberg University Hospital
Career Start Year 2010
Number of shared co-authors 3
University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Cancer Institute, Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 2
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 4
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 11
Semmelweis University
Career Start Year 2006
Number of shared co-authors 0
Saint-Louis Hospital
Career Start Year 2005
Number of shared co-authors 4
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 7
Washington University School of Medicine
Career Start Year 2001
Number of shared co-authors 6
Intermountain Medical Center
Career Start Year 2001
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 3
Merck & Co.
Career Start Year 1998
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 7
Moffitt Cancer Center
Career Start Year 1992
Number of shared co-authors 2
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 4
Fred Hutchinson Cancer Research Center
Career Start Year 1989
Number of shared co-authors 4
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 1984
Number of shared co-authors 6
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1982
Number of shared co-authors 1
University of Utah
Career Start Year 1982
Number of shared co-authors 5
Center for Cancer Research, National Cancer Institute
Career Start Year 1981
Number of shared co-authors 5
National Cancer Institute, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 3
Institute for Biomedical Research August Pi I Sunyer
Career Start Year 1981
Number of shared co-authors 7
National Cancer Institute, National Institutes of Health
Career Start Year 1979
Number of shared co-authors 5
Sapienza University.
Career Start Year 1968
Number of shared co-authors 7

Collaborators

University of Washington, USA Brotman Baty Institute for Precision Medicine
Co-authored papers 5
University of Washington
Co-authored papers 4
The University of Chicago
Co-authored papers 3
National Institutes of Health
Co-authored papers 2
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 2
University of North Carolina at Chapel Hill
Co-authored papers 2
UT MD Anderson Cancer Center
Co-authored papers 2
University of Pavia & S. Matteo Hospital
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
University Hospital Heidelberg
Co-authored papers 2
University of Washington
Co-authored papers 2
University of Washington
Co-authored papers 2
Invitae Corporation
Co-authored papers 2
Adelaide Medical School, University of Adelaide
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
University of Washington
Co-authored papers 1
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Washington University School of Medicine in St. Louis
Co-authored papers 1
University of Washington
Co-authored papers 1
Stanford University
Co-authored papers 1
Broad Institute of MIT and Harvard
Co-authored papers 1
Co-authored papers 1
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 1
University of Texas MD Anderson Cancer Center
Co-authored papers 1
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Houston Methodist Hospital
Co-authored papers 1
NewYork-Presbyterian Hospital
Co-authored papers 1